- ·The complete investor list: 12 names
- ·Watch Pathalys Pharma: the Monday email on marks, rounds and moves
Pathalys Pharma funding history
No funding rounds for Pathalys Pharma are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Pathalys Pharma valuation
Pathalys Pharma's last known valuation is $295 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How Pathalys Pharma's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Pathalys Pharma, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about Pathalys Pharma
- What is Pathalys Pharma worth?
- Pathalys Pharma's last known valuation is $295.0M.
- How much has Pathalys Pharma raised?
- Pathalys Pharma has raised $266.0M in total funding across its recorded rounds.